Literature DB >> 16737981

Cardiovascular risk estimation: important but may be inaccurate.

Vishnu Madhok1, Tom Fahey.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16737981      PMCID： PMC1479687          DOI： 10.1136/bmj.38849.517257.DE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.

Authors:  P Brindle; A Beswick; T Fahey; S Ebrahim
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

2.  Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study.

Authors:  Douglas G Manuel; Kelvin Kwong; Peter Tanuseputro; Jenny Lim; Cameron A Mustard; Geoffrey M Anderson; Sten Ardal; David A Alter; Andreas Laupacis
Journal:  BMJ       Date:  2006-05-31

3.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

4.  The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.

Authors:  Peter M Brindle; Alex McConnachie; Mark N Upton; Carole L Hart; George Davey Smith; Graham C M Watt
Journal:  Br J Gen Pract       Date:  2005-11       Impact factor: 5.386

5.  Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Authors:  Peter Brindle; Jonathan Emberson; Fiona Lampe; Mary Walker; Peter Whincup; Tom Fahey; Shah Ebrahim
Journal:  BMJ       Date:  2003-11-29
  5 in total
  4 in total

Review 1.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

2.  Cardiovascular risk assessment of Bulgarian urban population: cross-sectional study.

Authors:  Mariana Dyakova; Elena Shipkovenska; Peter Dyakov; Plamen Dimitrov; Svetla Torbova
Journal:  Croat Med J       Date:  2008-12       Impact factor: 1.351

Review 3.  The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women.

Authors:  LaPrincess C Brewer; Anna Svatikova; Sharon L Mulvagh
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

4.  Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.

Authors:  Rebecca K Simmons; Ruth L Coleman; Hermione C Price; Rury R Holman; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  Diabetes Care       Date:  2008-12-29       Impact factor: 17.152
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.